Crossing the Line Between Food and Drugs
This article was originally published in RPM Report
In the era of “nutraceuticals,” the lines between a food, a dietary supplement, a drug can be hard to define—even though they make a huge difference in the regulatory standards that apply. In a March 5 Warning Letter to Breathable Foods Inc., however, the agency drew a very bright line when it comes to inhaled caffeine: the role played by the human epiglottis.
You may also be interested in...
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.
With Pataday Once Daily Relief (0.2% olopatadine) and Twice Daily (0.1%), Alcon adds allergy treatment to its lineup of OTC drops indicated for dry eye and redness. “Obviously, eye allergy will become a much bigger part of the portfolio for us,” says US vision care GM Sean Clark.